The Global Microbiome Therapeutics Market Size is expected to grow from USD 289.8 Million in 2025 to USD 5789.1 Million by 2035, at a CAGR of 34.91% during the forecast period 2026-2035.
The Microbiome Therapeutics Market refers to the global industry that develops and sells treatments that change the human microbiome for disease prevention and control, and disease treatment.
This comprehensive market research report provides an in-depth analysis of the Microbiome Therapeutics market, with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.
The Global Microbiome Therapeutics Market Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.
Key Players in Global Microbiome Therapeutics Market
- Seres Therapeutics
- Vedanta Biosciences
- Ferring Pharmaceuticals
- Rebiotix Inc.
- 4D Pharma plc
- Second Genome Inc.
- Synlogic Inc.
- Enterome SA
- Finch Therapeutics Group Inc.
- Assembly Biosciences Inc.
- AOBiome LLC
- MaaT Pharma
Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions
Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR4784
Market Segmentation:
By Type
- Transplantation
- Drugs
By Disease Indication
- Clostridium Difficile Infection (CDI)
- Oncology-Support Settings, Vaginal Health
- Dermatology
- Inflammatory Bowel Disease
- Others
Key Insights Covered in the Global Microbiome Therapeutics Market Size & Industry Forecast Report (2020–2035):
1. Detailed analysis of the Global Microbiome Therapeutics Market Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.
2. Thorough assessment of Microbiome Therapeutics Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.
3. In-depth Microbiome Therapeutics Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.
4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Microbiome Therapeutics Market Share.
5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.
6. Regional regulatory framework assessment and policy impact analysis influencing the Microbiome Therapeutics Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term Global Microbiome Therapeutics Market Growth.
Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR4784
Industry Developments:
In March 2026, MaaT Pharma announced that its microbiome therapy MaaT013 (Xervyteg) is under European Medicines Agency (EMA) review, positioning it as a potential first-in-class microbiome drug in oncology, signaling major regulatory progress in Europe.
In January 2026, the U.S. Food and Drug Administration granted Investigational New Drug (IND) clearance to a microbiome-based therapy (MH002), enabling a Phase 2b clinical trial for ulcerative colitis. This highlights strong regulatory support and accelerating clinical development in microbiome therapeutics.
In January 2026, a new microbiome research center was launched to focus on gut microbiome-based therapeutics for diseases like IBD, obesity, and liver disorders, emphasizing country-specific microbiome data for precision medicine and future therapeutic development.
Regional Analysis for Microbiome Therapeutics Market:
✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Frequently asked questions:
➥ What is the market size of the Microbiome Therapeutics market?
➥ What is the market growth rate of the Microbiome Therapeutics market?
➥ What are the Microbiome Therapeutics market opportunities and threats faced by the vendors in the global Microbiome Therapeutics Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Microbiome Therapeutics market?
➥ What are the different sales, marketing, and distribution channels in the global industry?
Unlock the full report now! @ https://www.decisionsadvisors.com/reports/microbiome-therapeutics-market
About the Decisions Advisors
Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.
We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.
Contact Us:
Company Name: Decision Advisors
Email: [email protected]
Phone: +1 303 800 4326 (US)
